In today's world, Amedalin has become a topic of great relevance and interest to a wide spectrum of people. Whether due to its impact on society, its historical relevance or its influence in different areas, Amedalin has captured the attention and curiosity of individuals of all ages and professions. Over the years, Amedalin has been the subject of debate, analysis and study, generating a large amount of information and opinions about it. In this article, we will explore the different aspects, perspectives and possible implications of Amedalin, addressing its importance from various perspectives and offering a comprehensive view of the topic.
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H22N2O |
Molar mass | 294.398 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Amedalin (UK-3540-1) is an antidepressant which was synthesized in the early 1970s but was never marketed.[1][2] It is a selective norepinephrine reuptake inhibitor, with no significant effects on the reuptake of serotonin and dopamine, and no antihistamine or anticholinergic properties.[2][3]